"During a conference on 'Cardiac Monitoring in a Complex Patient Care Environment' … A slow increase in the use of the relatively expensive implantable defibrillators was predicted. MED-TRONIC, which has such a device under development, is expected to enter the market in 1984 and may stir more interest."
"BIOSONICS (Philadelphia) is finally coming out with a delayed offering totaling 20 mln shares (maximum) at $0.05 each. If the maximum number of shares are sold, the company will have raised $1 mln ($0.9 mln in net proceeds) for 11.4% of its outstanding common stock …" BIOSONICS' "claim to fame will be the male electronic genital stimulator, a self-contained, electronic device inserted rectally and controlled by the user to initiate the physiological process culminating in an erection."
"NATIONAL MEDICAL CARE (Boston), who pioneered free-standing dialysis centers in the 1970's, is focusing on diabetic self-management. It has opened two self-care centers (New York and Dallas) where insulin-using patients are taught to bring and keep their blood glucose within normal range."
These items, taken from the Jan. 4, 1982, issue of BIOMEDICAL BUSINESS INTERNATIONAL (this publication's predecssor) suggest how many things have changed in the med-tech environment over the past 25 years — and have stayed the same: Medtronic remains strong in implantable defibrillators and new ventures keep being developed; companies are raising money via stock sales and innovative ideas are being tested to reach specific disease states and patient groups (though drugs, not devices, now dominate the erectile dysfunction market).
BIOMEDICAL BUSINESS INTERNATIONAL was launched in 1977 (though we don't have the first five years of issues in our archives) and then was purchased by the Thomson Corp. in 1994. Thus, 2007 marks this publication's 30th year in covering medical technology (with the newsletter group purchased by Thompson Publishing Group of Washington D. C. last year).
The name of the publication was changed to BBI Newsletter in 1994 and then, last year, to Biomedical Business & Technology, to emphasize the intrinsic connection between medical technologies and business development. And over the past 12 years, this publication has been the foundation for numerous spin-off products: Cardiovascular Device Update in 1995, Medical Device Daily (first launched as Medical Device Week in 1997), Diagnostics & Imaging Week in 1998, Medical Technology & Devices Week in 2003 and numerous sourcebooks convering various sectors of med-tech.
The Jan. 4, 1982, issue is a loose-leaf product, rather than bound, and just 16 pages. The layout isn't particularly wonderful, the type style and organization generally reflecting a pre-desktop publishing era, but some of the main categories then are the same as those in this issue (though with different names): "International Scene," "Acquisitions, Divestments, Agreements," "Business Briefs," "New Products & Techniques" — the word "Techniques" seeming now rather antiquated as compared to the current ubiquitous "technologies." As with this issue of BB&T in your hand, the 1982 issue is replete with the names of companies and organizations (more than 200), many still with us but most now gone or merged into other companies.
We promise that BB&T under its new ownership will maintain the tradition that the publication has pursued so well over the past 29 years, bringing you an overview and understanding of key med-tech and biomedical sectors as these areas continue to change and develop — some companies and technologies rising in importance, some fading away, both developmental and mature technologies bringing important therapies to the world.
A promise, of course, is just words. But words, and conversations with the med-tech community, are what we do best. And we ask you and potential readers to share the important words that describe this industry now and into the future.